* MiMedx Group Inc MDXG.OQ MDXG.O is expected to report
results on November 2.
* The Marietta, Georgia-based company is expected to report
revenue of $60.26 million, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for MiMedx Group Inc is for
a loss of 8 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for MiMedx Group
Inc is $10, about 31.5% above its last closing price
of $6.85.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 -0.08 -0.07 -0.03 Beat 59.1
Mar. 31 2021 -0.19 -0.19 -0.09 Beat 52.6
Dec. 31 2020 -0.05 -0.05 -0.17 Missed -240
This summary was machine generated October 30 at 00:58 GMT. All
figures in US dollars unless otherwise stated